NCT01925274 2019-01-08A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal CancerPfizerPhase 2 Terminated19 enrolled 32 charts
NCT01937715 2016-08-18A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal CancerPfizerPhase 1/2 Terminated18 enrolled 23 charts